NARMS Cooperative Agreement Program to Strengthen Antibiotic Resistance Surveillance in Retail Food Specimens
Food and Drug Administration
Forecasted
Application OpensNov 5, 2024
DeadlineRolling
GeographyNot specified
Eligible Applicants
Native American tribal governments (Federally recognized)For profit organizations other than small businessesSpecial district governmentsState governmentsPublic housing authorities/Indian housing authoritiesCounty governmentsSmall businessesNonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher educationNative American tribal organizations (other than Federally recognized tribal governments)Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher educationIndependent school districtsCity or township governmentsPublic and State controlled institutions of higher educationPrivate institutions of higher education
Overview
This Funding Opportunity Announcement (FOA) issued by the Food and Drug Administration (FDA), Center for Veterinary Medicine (CVM), builds upon the National Antimicrobial Resistance Monitoring System (NARMS) which was initiated in 1996 as one of the key activities in a national action plan to combat antibiotic resistance threats. The purpose of this FOA is to protect and promote public health by enhancing, strengthening and sustaining antibiotic resistance monitoring in retail food specimens within the NARMS program. The NARMS cooperative agreements is intended to improve the detection of antibiotic resistance among bacteria in food commodities, as well as expand to new sites to expand the scope of sampling. Measurable outcomes of the program will be in alignment with the NARMS Objectives.